The United States has the highest maternal mortality rate of any high-income country, a crisis perpetuated by the lack of ...

Ernst & Young study shows 85% of participating organization leaders are seeing better patient outcomes, and nearly 75% report ...

The pharmacy benefit manager (PBM) industry is under pressure to shift to models that avoid conflicts of interest and ...

Current treatment options have improved survival rates but have not provided a cure. Eventually, initial therapies stop ...

While heritable human genome editing is banned in the United States, across Europe and much of the world, the technology ...

The Teal Wand was recently approved by the FDA as the first self-collection device to screen for cervical cancer, a major step forward for accessible women’s health, according to Rahma S. Mkuu, Ph.D., ...

Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, ...

Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation ...

Medicare Advantage plans have drawn the ire of lawmakers for aggressive coding. Investigations are underway. Some hope ...

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Satellos Bioscience Chief Scientific Officer discusses early-stage trials of the company's Duchenne muscular dystrophy drug, ...